These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1686398)

  • 21. Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats.
    Hudson JL; van Horne CG; Strömberg I; Brock S; Clayton J; Masserano J; Hoffer BJ; Gerhardt GA
    Brain Res; 1993 Oct; 626(1-2):167-74. PubMed ID: 8281427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Yates TM
    Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The dopamine-gamma aminobutyric acid interaction in the striatum of the rat is differently regulated by dopamine D-1 and D-2 types of receptor: evidence obtained with rotational behavioural experiments.
    Herrera-Marschitz M; Ungerstedt U
    Acta Physiol Scand; 1987 Mar; 129(3):371-80. PubMed ID: 3033996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. D1-dopamine receptor agonists selectively activate striatal c-fos independent of rotational behaviour.
    Robertson HA; Peterson MR; Murphy K; Robertson GS
    Brain Res; 1989 Dec; 503(2):346-9. PubMed ID: 2532558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peter H. Kelly, Paul W. Seviour and Susan D. Iversen (1975) "Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum" [Brain Res. 94 (3) 507-522].
    Iversen SD
    Brain Res; 2016 Aug; 1645():36-7. PubMed ID: 27287245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity.
    Paul ML; Currie RW; Robertson HA
    Neuroscience; 1995 May; 66(2):347-59. PubMed ID: 7477877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transection of corticostriatal afferents reduces amphetamine- and apomorphine-induced striatal Fos expression and turning behaviour in unilaterally 6-hydroxydopamine-lesioned rats.
    Cenci MA; Björklund A
    Eur J Neurosci; 1993 Aug; 5(8):1062-70. PubMed ID: 8281310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-induced rotation in rats without lesions: behavioral and neurochemical indices of a normal asymmetry in nigro-striatal function.
    Jerussi TP; Glick SD
    Psychopharmacology (Berl); 1976 Jun; 47(3):249-60. PubMed ID: 823560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Costall B; Naylor RJ; Pycock C
    Eur J Pharmacol; 1976 Feb; 35(2):276-83. PubMed ID: 942921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
    Sindhu KM; Banerjee R; Senthilkumar KS; Saravanan KS; Raju BC; Rao JM; Mohanakumar KP
    Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of naloxone upon apomorphine-induced rotational behavior in rats with electrolytic versus chemolytical lesions of the substantia nigra.
    Quock RM; Sadowski JA
    Pharmacol Res Commun; 1986 Jul; 18(7):663-72. PubMed ID: 3763674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites.
    Giambalvo CT; Snodgrass SR
    Brain Res; 1978 Sep; 152(3):555-66. PubMed ID: 308384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitization of rotation behavior in rats with unilateral 6-hydroxydopamine or kainic acid-induced striatal lesions.
    Norman AB; Wyatt LM; Hildebrand JP; Kolmonpunporn M; Moody CA; Lehman MN; Sanberg PR
    Pharmacol Biochem Behav; 1990 Dec; 37(4):755-9. PubMed ID: 2128758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intranigral injections of SCH 23390 inhibit amphetamine-induced rotational behavior.
    Yurek DM; Hipkens SB
    Brain Res; 1993 Sep; 623(1):56-64. PubMed ID: 8221093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopaminergic grafts in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats.
    Robertson GS; Fine A; Robertson HA
    Brain Res; 1991 Jan; 539(2):304-11. PubMed ID: 1675908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine receptors mediate drug-induced but not Pavlovian conditioned contralateral rotation in the unilateral 6-OHDA animal model.
    Carey RJ
    Brain Res; 1990 May; 515(1-2):292-8. PubMed ID: 2113414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration.
    Wenning GK; Granata R; Laboyrie PM; Quinn NP; Jenner P; Marsden CD
    Mov Disord; 1996 Sep; 11(5):522-32. PubMed ID: 8866493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced GABA function in the angular complex (lateral periaqueductal grey matter and adjacent reticular formation) alters the postural component of striatal- or nigral-derived circling.
    Reavill C; Muscatt S; Leigh PN; Jenner P; Marsden CD
    Exp Brain Res; 1984; 56(1):1-11. PubMed ID: 6468558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropharmacological studies on D145 (1,3-dimethyl-5-aminoadamantan).
    Costall B; Naylor RJ
    Psychopharmacologia; 1975 Jul; 43(1):53-61. PubMed ID: 1099605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor.
    Kirik D; Rosenblad C; Björklund A
    Eur J Neurosci; 2000 Nov; 12(11):3871-82. PubMed ID: 11069582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.